You are here
Closed
NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.
-
PA-15-336: Imaging Diagnostics of Dental Diseases and Conditions (Caries, Periodontal Disease, Cracked Teeth, and Pulp Vitality) (R41/R42)
Release Date: 08-20-2015Open Date: 12-05-2015 Due Dates: Multiple Close Date: 09-07-2018The focus of this funding opportunity announcement (FOA) is to encourage the development of devices that will improve diagnosis of the following oral diseases and conditions: 1) caries after the appearance of white spot lesions and before penetration through the enamel-dentin junction; 2) severity and status of periodontal disease; 3) cracks in teeth and the depth of their extension into the tooth ...
STTRPhase IDepartment of Health and Human Services -
PA-15-335 : Imaging Diagnostics of Dental Diseases and Conditions (Caries, Periodontal Disease, Cracked Teeth, and Pulp Vitality) (R43/R44)
Release Date: 08-20-2015Open Date: 12-05-2015 Due Dates: Multiple Close Date: 09-07-2018The focus of this funding opportunity announcement (FOA) is to encourage the development of devices that will improve diagnosis of the following oral diseases and conditions: 1) caries after the appearance of white spot lesions and before penetration through the enamel-dentin junction; 2) severity and status of periodontal disease; 3) cracks in teeth and the depth of their extension into the tooth ...
SBIRPhase IDepartment of Health and Human Services -
001: Novel Tools and Devices for Animal Research Facilities and to Support the Care of Animal Models (R43/R44)
Release Date: 04-16-2015Open Date: 08-05-2015 Due Dates: Multiple Close Date: 09-05-2018Many NIH-funded research projects rely on vertebrate and invertebrate animals to study fundamentals of biology and physiology, to investigate pathological conditions, to build models of human diseases, and to design novel therapies and translational procedures. ORIP plays a vital role in the area of NIH-funded animal model research by supporting specialized animal research facilities and the devel ...
SBIRPhase IDepartment of Health and Human Services -
001: Development of Novel Tools and Devices to Support the Care of Animal Models and Animal Care Research Facilities (R41/R42)
Release Date: 04-16-2015Open Date: 08-05-2015 Due Dates: Multiple Close Date: 09-05-2018Many NIH-funded research projects rely on vertebrate and invertebrate animals to study fundamentals of biology and physiology, to investigate pathological conditions, to build models of human diseases, and to design novel therapies and translational procedures. ORIP plays a vital role in the area of NIH-funded animal model research by supporting specialized animal research facilities and the devel ...
STTRPhase IDepartment of Health and Human Services -
PA-15-354 : SBIR Technology Transfer (R43/R44)
Release Date: 09-21-2015Open Date: 12-05-2015 Due Dates: Multiple Close Date: 09-05-2018The SBIR Technology Transfer (SBIR-TT) Funding Opportunity Announcement (FOA) is intended to help move commercially-viable technologies from the NIH Intramural Program to the marketplace. Small Business Concerns (SBCs) are encouraged to submit applications that further develop available technologies from the NIH Intramural Program and bring them to the commercial market. While universities can spi ...
SBIRPhase IDepartment of Health and Human Services -
001: NINDS Exploratory Clinical Trials for Small Business (R44)
Release Date: 06-15-2015Open Date: 08-05-2015 Due Dates: Multiple Close Date: 04-05-2018Purpose The NINDS is committed to advancing treatments for people burdened by the neurological disorders that fall under the NINDS mission. Traditionally, large pharmaceutical and biotechnology companies, as well as venture capital firms, have provided the resources needed to conduct the clinical studies required to fully develop and commercialize biomedical products and technologies. More recentl ...
SBIRPhase IIDepartment of Health and Human Services -
001: NINDS Exploratory Clinical Trials for Small Business (R42)
Release Date: 06-15-2015Open Date: 08-05-2015 Due Dates: Multiple Close Date: 04-05-2018Purpose The NINDS is committed to advancing treatments for people burdened by the neurological disorders that fall under the NINDS mission. Traditionally, large pharmaceutical and biotechnology companies, as well as venture capital firms, have provided the resources needed to conduct the clinical studies required to fully develop and commercialize biomedical products and technologies. More recent ...
STTRPhase IIDepartment of Health and Human Services -
PA-15-052: HHS SBIR PA-15-052
Release Date: 11-24-2014Open Date: 03-05-2015 Due Dates: Multiple Close Date: 01-07-2018The NIH and other research sponsors provide significant funding to support the development of new technologies to support biomedical and behavioral research, through a variety of grant mechanisms, including NIH’s R01, R21, P01, P41, and P50 basic research grants. This investment has resulted in the development of innovative technologies, including hardware (e.g., instruments, devices, etc.), sof ...
SBIRPhase IDepartment of Health and Human Services -
PA-15-077: HHS SBIR PA-15-077
Release Date: 12-18-2014Open Date: 03-05-2015 Due Dates: Multiple Close Date: 01-07-2018Despite advances in the treatment of chronic viral hepatitis B and C, the persistence of these and the emergence of other hepatitis viruses continue to remain a public health challenge in the United States. Currently, it is estimated that 3.5 to 5.3 million persons in the United States are afflicted by viral hepatitis. The consequences of acute and chronic viral hepatitis vary, but can be severe a ...
SBIRPhase IDepartment of Health and Human Services -
PA-15-076: HHS STTR PA-15-076
Release Date: 12-18-2014Open Date: 03-05-2015 Due Dates: Multiple Close Date: 01-07-2018Despite advances in the treatment of chronic viral hepatitis B and C, the persistence of these and the emergence of other hepatitis viruses continue to remain a public health challenge in the United States. Currently, it is estimated that 3.5 to 5.3 million persons in the United States are afflicted by viral hepatitis. The consequences of acute and chronic viral hepatitis vary, but can be severe a ...
STTRPhase IDepartment of Health and Human Services